Profile data is unavailable for this security.
About the company
Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases.
- Revenue in USD (TTM)161.73bn
- Net income in USD3.07bn
- Incorporated2001
- Employees67.70k
- LocationCentene Corp7700 Forsyth BlvdST. LOUIS 63105-1807United StatesUSA
- Phone+1 (314) 725-4477
- Fax+1 (302) 655-5049
- Websitehttps://www.centene.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tenet Healthcare Corp | 20.97bn | 3.13bn | 15.62bn | 78.14k | 5.25 | 4.07 | 3.26 | 0.7446 | 31.26 | 31.26 | 209.81 | 40.32 | 0.7364 | 9.49 | 7.15 | 268,376.30 | 13.86 | 3.61 | 20.23 | 5.09 | 82.61 | 82.97 | 18.83 | 4.95 | 1.52 | 5.37 | 0.6145 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
| Natera Inc | 1.36bn | -292.12m | 16.71bn | 3.28k | -- | 19.93 | -- | 12.28 | -2.47 | -2.47 | 11.38 | 6.78 | 0.9841 | 15.01 | 4.57 | 414,534.80 | -21.13 | -36.17 | -26.88 | -46.60 | 53.85 | 45.88 | -21.47 | -56.15 | 4.01 | -- | 0.3032 | -- | 31.99 | 33.26 | 20.63 | -- | 58.81 | -- |
| Quest Diagnostics Inc | 9.54bn | 838.00m | 18.05bn | 40.00k | 21.71 | 2.66 | 13.52 | 1.89 | 7.45 | 7.45 | 84.79 | 60.79 | 0.645 | 34.77 | 7.18 | 238,475.00 | 5.87 | 9.28 | 6.77 | 10.81 | 32.94 | 36.64 | 9.10 | 12.97 | 1.17 | 8.87 | 0.4746 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
| Molina Healthcare Inc | 39.20bn | 1.14bn | 18.24bn | 18.00k | 16.19 | 3.81 | 13.77 | 0.4654 | 19.70 | 19.70 | 674.97 | 83.68 | 2.56 | -- | 13.71 | 2,177,722.00 | 7.47 | 7.62 | 16.58 | 16.80 | 16.12 | 15.99 | 2.92 | 3.04 | -- | 14.83 | 0.3465 | 0.00 | 6.56 | 12.52 | 37.75 | 9.06 | 22.87 | -- |
| Labcorp Holdings Inc | 12.71bn | 435.50m | 20.43bn | 67.00k | 47.33 | 2.50 | 19.35 | 1.61 | 5.16 | 5.16 | 150.40 | 97.61 | 0.7162 | 19.41 | 5.93 | 189,743.30 | 2.46 | 6.27 | 3.00 | 7.37 | 27.92 | 32.33 | 3.44 | 9.51 | 1.30 | 5.59 | 0.455 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
| Centene Corp | 161.73bn | 3.07bn | 29.59bn | 67.70k | 10.16 | 1.09 | 6.89 | 0.1829 | 5.77 | 5.77 | 303.72 | 53.53 | 1.94 | -- | 9.57 | 2,388,863.00 | 3.66 | 2.58 | 6.39 | 3.99 | 10.37 | 11.59 | 1.89 | 1.37 | -- | 4.06 | 0.3911 | 0.00 | 6.54 | 20.70 | 124.79 | 24.59 | 3.43 | -- |
| Humana Inc | 115.01bn | 1.36bn | 33.72bn | 67.60k | 24.80 | 1.92 | 14.03 | 0.2932 | 11.29 | 11.29 | 948.23 | 145.88 | 2.17 | -- | -- | 1,701,331.00 | 2.72 | 7.57 | -- | -- | -- | -- | 1.25 | 3.35 | -- | 5.38 | 0.4249 | 12.54 | 14.54 | 13.33 | -11.30 | 7.65 | 10.41 | 13.25 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2024 | 58.36m | 11.10% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 28.04m | 5.33% |
| Capital Research & Management Co. (World Investors)as of 30 Jun 2024 | 26.64m | 5.06% |
| Harris Associates LPas of 30 Jun 2024 | 24.89m | 4.73% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 23.36m | 4.44% |
| Fidelity Management & Research Co. LLCas of 30 Jun 2024 | 21.78m | 4.14% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 21.21m | 4.03% |
| Wellington Management Co. LLPas of 30 Jun 2024 | 17.68m | 3.36% |
| Geode Capital Management LLCas of 30 Jun 2024 | 12.68m | 2.41% |
| Politan Capital Management LPas of 30 Jun 2024 | 12.14m | 2.31% |
